tradingkey.logo
tradingkey.logo

Apyx Medical Corp

APYX
3.680USD
+0.190+5.44%
取引時間 ET15分遅れの株価
139.18M時価総額
損失額直近12ヶ月PER

Apyx Medical Corp

3.680
+0.190+5.44%

詳細情報 Apyx Medical Corp 企業名

Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.

Apyx Medical Corpの企業情報

企業コードAPYX
会社名Apyx Medical Corp
上場日Jul 22, 1983
最高経営責任者「CEO」Goodwin (Charles D)
従業員数220
証券種類Ordinary Share
決算期末Jul 22
本社所在地5115 Ulmerton Rd
都市CLEARWATER
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号33760-4004
電話番号18005372790
ウェブサイトhttps://apyxmedical.com/
企業コードAPYX
上場日Jul 22, 1983
最高経営責任者「CEO」Goodwin (Charles D)

Apyx Medical Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy Levine
Ms. Wendy Levine
Independent Director
Independent Director
--
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
Domestic
7.78M
68.37%
International
3.60M
31.63%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
Nantahala Capital Management, LLC
8.14%
Archon Capital Management LLC
8.00%
Vanderfelt (William Weeks)
7.70%
Royce Investment Partners
6.03%
Vizirgianakis (Stavros G)
4.26%
他の
65.87%
株主統計
株主統計
比率
Nantahala Capital Management, LLC
8.14%
Archon Capital Management LLC
8.00%
Vanderfelt (William Weeks)
7.70%
Royce Investment Partners
6.03%
Vizirgianakis (Stavros G)
4.26%
他の
65.87%
種類
株主統計
比率
Hedge Fund
17.02%
Individual Investor
13.42%
Investment Advisor
11.62%
Investment Advisor/Hedge Fund
8.99%
Private Equity
0.37%
Family Office
0.23%
Research Firm
0.10%
Venture Capital
0.05%
他の
48.19%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
93
15.65M
47.11%
--
2025Q3
106
16.17M
54.10%
-179.30K
2025Q2
111
16.35M
54.58%
+38.20K
2025Q1
115
16.92M
61.27%
-6.24M
2024Q4
121
17.05M
55.05%
+3.13M
2024Q3
126
13.93M
65.05%
-228.66K
2024Q2
141
15.10M
68.01%
-305.66K
2024Q1
168
15.41M
70.58%
-9.04M
2023Q4
180
18.49M
72.63%
-941.37K
2023Q3
175
19.43M
74.54%
-988.75K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Nantahala Capital Management, LLC
3.34M
8.83%
+80.00K
+2.46%
Jun 30, 2025
Archon Capital Management LLC
3.28M
8.68%
-15.26K
-0.46%
Jun 30, 2025
Vanderfelt (William Weeks)
3.16M
8.35%
--
--
Jun 23, 2025
Royce Investment Partners
2.44M
6.45%
-85.76K
-3.40%
Jun 30, 2025
Vizirgianakis (Stavros G)
1.75M
4.62%
--
--
Jun 23, 2025
The Vanguard Group, Inc.
1.48M
3.9%
--
--
Jun 30, 2025
Silverberg Bernstein Capital Management, LLC
986.50K
2.61%
+89.77K
+10.01%
Sep 30, 2025
Commonwealth Financial Network
663.54K
1.75%
+78.00K
+13.32%
Jun 30, 2025
Horizon Kinetics LLC
615.00K
1.63%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
495.99K
1.31%
+6.87K
+1.40%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0.02%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
比率0.02%
Avantis US Equity ETF
比率0%
Avantis US Small Cap Equity ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Apyx Medical Corpの上位5名の株主は誰ですか?

Apyx Medical Corpの上位5名の株主は以下のとおりです。
Nantahala Capital Management, LLCは3.34M株を保有しており、これは全体の8.83%に相当します。
Archon Capital Management LLCは3.28M株を保有しており、これは全体の8.68%に相当します。
Vanderfelt (William Weeks)は3.16M株を保有しており、これは全体の8.35%に相当します。
Royce Investment Partnersは2.44M株を保有しており、これは全体の6.45%に相当します。
Vizirgianakis (Stavros G)は1.75M株を保有しており、これは全体の4.62%に相当します。

Apyx Medical Corpの株主タイプ上位3種は何ですか?

Apyx Medical Corpの株主タイプ上位3種は、
Nantahala Capital Management, LLC
Archon Capital Management LLC
Vanderfelt (William Weeks)

Apyx Medical Corp(APYX)の株式を保有している機関の数はいくつですか?

2025Q4時点で、Apyx Medical Corpの株式を保有している機関は93社あり、保有株式の総市場価値は約15.65Mで、全体の47.11%を占めています。2025Q3と比較して、機関の持ち株は-6.99%増加しています。

Apyx Medical Corpの最大の収益源は何ですか?

FY2025Q2において、--部門がApyx Medical Corpにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
KeyAI